Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation
Completed · Not applicable
Conditions studied: Congestive Heart Failure
In brief
EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalization due to heart failure exacerbation.
Key facts
- Study ID
- NCT03043261
- Run by
- Duke University
- People needed
- 3
- Starts
- 2018-01-29
- Expected to finish
- 2018-04-07
- Last updated by the study team
- 2018-05-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult male and female patients, age ≥ 18 hospitalized at Duke inpatient service because of heart failure
- NYHA Class ≥ II
You may not qualify if…
- Significant cognitive impairment, indicated as a mini-mental state exam (MMSE) total score of 23 or lower
- Lack of convenient internet access outside of hospital
- Alcohol or other drug dependence/abuse within past 90 days as evaluated by review of medical record and patient interview (SCID)
- Severe physical disability (visual, sensory or motor) that may interfere with study participation (assessment, online interactive learning)
- History or presence of psychoses, bipolar disorder, and/or severe personality disorders as evaluated by review of medical record and patient interview (SCID)
- Life-threatening co-morbidity with the likelihood of 50% mortality in one year
- Active suicidal ideations
- Female patients of childbearing potential
- Treatment with electroconvulsive therapy or transcranial magnetic stimulation within past 90 days
- Uncorrected hypothyroidism or hyperthyroidism
Where it is running
- Pamela Bonner — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.